First Time Loading...

Globeimmune Inc
OTC:GBIM

Watchlist Manager
Globeimmune Inc Logo
Globeimmune Inc
OTC:GBIM
Watchlist
Price: 0.0002 USD Market Closed
Updated: May 12, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

9.8m
-15%
Assets
Growth Rates:
1 Year
-37%
3 Years
-
5 Years
-
7 Years
-
10 Years
-
7.6m
-11%
Liabilities
Growth Rates:
1 Year
-33%
3 Years
-
5 Years
-
7 Years
-
10 Years
-
2.2m
-28%
Equity
Growth Rates:
1 Year
-48%
3 Years
-
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
Globeimmune Inc

9.8m
Assets
7.6m
Liabilities
9.8m
Assets
7.6m
Liabilities
Current Assets 9.4m
Cash & Short-Term Investments 8.7m
Other Current Assets 756k
Non-Current Assets 321.3k
PP&E 190.6k
Other Non-Current Assets 130.6k
Current Liabilities 4.1m
Accounts Payable 407.7k
Accrued Liabilities 286.7k
Other Current Liabilities 3.5m
Non-Current Liabilities 3.5m
Other Non-Current Liabilities 3.5m

Balance Sheet
Globeimmune Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015
Assets
Cash & Cash Equivalents
20
15
2
6
17
10
Cash Equivalents
20
15
2
6
17
10
Other Current Assets
0
0
1
1
1
1
Total Current Assets
21
16
3
7
18
11
PP&E Net
3
2
1
0
0
0
PP&E Gross
0
0
1
0
0
0
Accumulated Depreciation
0
0
11
0
12
0
Other Long-Term Assets
0
0
0
0
0
0
Total Assets
24
N/A
18
-25%
4
-76%
7
+75%
18
+148%
12
-37%
Liabilities
Accounts Payable
1
1
3
2
1
0
Accrued Liabilities
1
1
1
1
1
1
Short-Term Debt
0
0
0
0
0
0
Other Current Liabilities
4
11
4
4
3
3
Total Current Liabilities
6
13
8
6
5
4
Long-Term Debt
0
0
0
0
0
0
Other Liabilities
24
24
17
12
8
4
Total Liabilities
30
N/A
38
+25%
26
-32%
19
-25%
13
-33%
9
-33%
Equity
Common Stock
151
163
175
188
0
0
Retained Earnings
158
182
196
199
223
225
Additional Paid In Capital
0
0
0
0
228
228
Total Equity
6
N/A
20
-209%
21
-8%
12
+45%
6
N/A
3
-47%
Total Liabilities & Equity
24
N/A
18
-25%
4
-76%
7
+75%
18
+148%
12
-37%
Shares Outstanding
Common Shares Outstanding
5
5
5
5
6
6

See Also

Summary
GBIM intrinsic value, competitors valuation, and company profile.
DCF Valuation
GBIM stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GBIM stock valuation using valuation multiples.
Wall Street Estimates
GBIM price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GBIM stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 136,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.